Cholera vaccine supply likely to remain limited for years, Gavi says

Gavi, the Vaccine Alliance forecasted that the global supply of oral cholera vaccine is likely to remain limited through 2025 if current outbreak trends continue.According to Gavi, around 48 million doses of oral cholera vaccine (OCV) were administered globally in 2021 and 2022 in response to dozens of outbreaks of the diarrheal illness. That is 10 million more doses than were needed in the previous 10 years combined.As a result of the increased demand, Gavi said the supply of OCV for preventive vaccination “will likely continue to be limited … and will need to be allocatedRead More